A patent ductus arteriosus (PDA) is a persistent connection between the aorta and the pulmonary artery resulting in left to right shunting. This connection is supposed to close shortly after birth ...

Cite this: Current Controversies in the Diagnosis and Treatment of Patent Ductus Arteriosus in Preterm Infants - Medscape - Aug 01, 2003. The DA of a very preterm infant has minimal constriction ...

Merit Medical Systems has enrolled the first patient in the multi-centre PREEMIE study to assess the efficacy and safety of ...

Merit Medical Systems, Inc. MMSI, on Monday, announced the enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus ...

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the ...

Merit Medical Systems announced today that investigators enrolled the first patient in a study of its Bloom micro occluder ...

prospective study of the Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in premature infants (PREEMIE study). PDA is a congenital heart condition that occurs when ...

As a result, the DA is more likely to remain patent and the resulting shunt may have important hemodynamic consequences. [4] Doppler echocardiography has given us a window to evaluate the real ...

Systems announced enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder ...